ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0314734733353267 0.35123885
NSC 600758 Null 0.0314734733353267 0.21299535
NSC 606498 Camptothecin Derivative 0.0314734733353267 0.44435566
NSC 610458 Camptothecin Derivative 0.0314734733353267 0.40678515
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0314734733353267 0.18565441
NSC 621322 Null 0.0314734733353267 0.20594131
NSC 622341 Null 0.0314734733353267 0.37273166
NSC 624233 Null 0.0314734733353267 -0.069702479
NSC 624474 Null 0.0314734733353267 -0.13781024
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0314734733353267 0.39526368
Total:126  Current:87    [First] [Prev] [Next] [Last]